Elsevier

Experimental Cell Research

Volume 253, Issue 2, 15 December 1999, Pages 511-518
Experimental Cell Research

Regular Article
Monocytically Differentiating HL60 Cells Proliferate Rapidly before They Mature

https://doi.org/10.1006/excr.1999.4660Get rights and content

Abstract

1α,25-Dihydroxyvitamin D3 (D3) provokes growth arrest and monocytic differentiation in myeloid cells. Although it is usually assumed that the cellular events leading to growth arrest start within one cell cycle of D3 addition, there is also evidence that D3 provokes the expression of proliferation-related genes and accelerates cell division. Herein we clarify the relationship between proliferation and maturation in differentiating HL60 cells. Cells were cultured singly, D3 was added at various stages of the cell cycle, the progeny were counted, and the proportions of mature monocytes were determined. Initially, the D3-treated cells proliferated at an accelerated rate, and they matured only later. If cells encountered D3 early in G1 they divided two to four times before maturing, and if they encountered D3 later in the cell cycle they underwent an extra division. Indomethacin slows HL60 cell multiplication by prolonging G1, and when these slower-growing cells were exposed to D3, they matured after the usual period but underwent one division less than indomethacin-free cells. Contrary to common assumptions, we conclude that promyeloid cells do not initiate growth arrest or monocytic maturation immediately after exposure to D3. Instead, an encounter with D3 early in G1 sets in train a complex differentiation program. This consists of 2–3 days of rapid proliferation—probably employing cell cycles with a shortened G1 phase—that is followed by growth arrest and maturation. As a result, a single D3-treated promyeloid cell gives rise to 10 or more mature monocytes. These observations not only explain why “differentiating” cells express proliferation-related characteristics soon after D3 addition, but they also show that the process of D3-induced monocytic differentiation is much more complex than has previously been realized.

References (23)

  • H. Temin

    Stimulation by serum of multiplication of stationary chicken cells

    J. Cell Physiol.

    (1971)
  • Cited by (35)

    • Regulation of FOXP3 expression in myeloid cells in response to all-trans-retinoic acid, interleukin 2 and transforming growth factor β

      2019, Developmental and Comparative Immunology
      Citation Excerpt :

      The second most upregulated gene was as ITGAM, which encodes adhesion molecule CD11b. The upregulation of CD11b in response to ATRA has been reported by many research groups in the past (Brown et al., 1999; Lee et al., 2002). The most surprising was to find significant upregulation of FOXP3 expression in response to ATRA in HL60 cells.

    • Low serum vitamin D levels are associated with shorter survival after first-line azacitidine treatment in patients with myelodysplastic syndrome and secondary oligoblastic acute myeloid leukemia

      2017, Clinical Nutrition
      Citation Excerpt :

      It has been long known that VitD is capable of inducing maturation of myeloid cell lines in vitro. After an initial burst of proliferation, terminal differentiation along the monocytic pathway could be observed resulting in growth arrest of several leukemic cell lines and primary cells [12,42]. However, treatment of MDS and AML patients with VitD resulted in highly variable and transient responses without clinical benefit when VitD was applied as monotherapy [14].

    • Developmental Vitamin D Availability Impacts Hematopoietic Stem Cell Production

      2016, Cell Reports
      Citation Excerpt :

      These findings led to in vivo studies and phase 1 clinical trials for the use of vitamin D as a differentiation agent for acute myeloid leukemia (AML), which ultimately proved to be unsuccessful because of hypercalcemia and heterogeneity of the AML subtypes tested (Marchwicka et al., 2014). Interestingly, although treatment of the HL-60 leukemia cell line with 1,25(OH)D3 required 18–20 hr of exposure for differentiation to begin (Mangelsdorf et al., 1984), an initial burst in proliferation was seen during early phases (Brown et al., 1999), similar to the effect on HSPCs observed here. Our data indicate that 1,25(OH)D3 stimulates proliferative HSPC expansion.

    • Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways

      2015, Biotechnology Advances
      Citation Excerpt :

      Moreover, transcription factors, including CCAAT/enhancer binding protein (C/EBP)α, RUNX1 and E proteins (Gentleman et al., 2004; Koschmieder et al., 2009; Tang et al., 2009; Wouters et al., 2009), and the epigenetic regulatory proteins HDACs, CBP/p300, PRMT1 and SON are reportedly involved in the initiation/progression of t(8;21) AML–M2 (Gelmetti et al., 1998; Shia et al., 2012). The anti-cancer activities of the active form of vitamin D, 1,25-dihydroxyvitamin D3 (VD3) (1), have long been linked to the ability of this compound to induce the differentiation of human myeloid leukemia cells into monocyte–macrophages (Brown et al., 1999; Okamoto et al., 2008), including in pro-myelocytic HL60, mouse myeloblastic leukemia M1 and histiocytic monoblast-like lymphoma U937 cells (Abe et al., 1981; Tanaka et al., 1983). VD3 (1) activates several signaling pathways, such as the MAPK and PI3K/AKT pathways, as well as lipid signaling pathways (Marchwicka et al., 2014).

    • Application of vitamin D and derivatives in hematological malignancies

      2012, Cancer Letters
      Citation Excerpt :

      Thus, the anti-proliferative and terminally-differentiating effects of vitamin D and analogs have become a focal point of investigation for the treatment of hematological malignancies, especially AML. The complexity of the initiation of vitamin D-induced differentiation and its relation to cell cycle systems was indicated in the observation that HL-60 cells initially responded to 1,25D treatment by proliferating rapidly prior to eventual growth arrest and monocytic differentiation [7]. This early proliferative burst was also observed in U937 cells, followed by elevated levels of specific cyclin-dependent kinase inhibitors, p21Waf1/Cip1 and p27Kip1.

    View all citing articles on Scopus
    1

    To whom correspondence and reprint requests should be addressed at Division of Immunity & Infection, Medical School, University of Birmingham, Birmingham B15 2TT, UK. Fax: 0121-414-3599. E-mail: [email protected].

    View full text